Table 1. Baseline characteristics of 127 PEG patients who were enrolled in Study 1.
| Group | Elemental diet (N=60) | Standard liquid diet (N=67) | P value |
|---|---|---|---|
| Gender (male/female) | 33/27 | 27/40 | 0.098 |
| Age (years)a | 79±8 | 81±7 | 0.88 |
| Indication for PEG: CVA/CNSD | 48/12 | 57/10 | 0.45 |
| Causes of hospitalization | |||
| Pneumonia | 43 | 47 | 0.95 |
| BTI | 12 | 15 | |
| UTI | 5 | 5 | |
| Amount of PEG feeding (ml)a | 900±0 | 1040±100 | 0.76 |
| Duration of PEG feeding (months)a | 21±4 | 17±4 | 0.66 |
| Period when the incidence of complications was observed (months)a | |||
| 11±7 | 12±9 | 0.74 | |
| Concurrent medical conditions | |||
| Chronic kidney disease | 3 | 4 | 0.81 |
| Chronic liver disease | 5 | 6 | 0.90 |
| COPD | 3 | 2 | 0.56 |
| Proton pump inhibitor use | 8 | 10 | 0.80 |
BTI, biliary tract infection; CNSD, central nervous system disorders; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; PEG, percutaneous endoscopic gastrostomy; UTI, urinary tract infection.
Values are number of patients except for age, the amount, the duration of PEG feeding, and the period when the incidence of complications was observed.
a
Each value shows mean±s.d.